Block’s earnings report comes during a slide in the stock price tied to reports that U.S. prosecutors were probing the company’s compliance practices.
Schlagwort-Archiv: CNBC
Apple announces largest-ever $110 billion share buyback as iPhone sales drop 10%
Apple CEO Tim Cook told CNBC that quarterly sales suffered from a difficult comparison to the year-earlier period.
Exxon Mobil reaches agreement with FTC, poised to close $60 billion Pioneer deal
The FTC will not block the deal now that the regulator and Exxon have reached a consent agreement, according to a source familiar with the matter.
Here’s what changed in the new Fed statement
This is a comparison of Wednesday’s Federal Open Market Committee statement with the one issued after the Fed’s previous policymaking meeting in March.
Fed keeps rates steady as it notes ‚lack of further progress‘ on inflation
With the decision to hold the line on rates, the committee noted a „lack of further progress“ in getting inflation back down to the central bank’s 2% target.
Why hundreds of U.S. banks may be at risk of failure
Of about 4,000 banks, 282 banks face threats from commercial real estate and higher interest rates, according to a study by Klaros Group.
Peloton CEO Barry McCarthy to step down, company to lay off 15% of staff as it looks to refinance debt
Peloton announced Thursday that CEO Barry McCarthy will be stepping down just over two years after he took over from founder John Foley.
Wayfair shares surge 17% after furniture retailer cuts losses by more than $100 million
Wayfair’s sales fell in the first quarter, but the furniture retailer narrowed its losses by over $100 million after cutting 13% of its staff.
Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold
The company reiterated its full-year 2024 sales guidance of roughly $4 billion, which includes revenue from the expected launch of its RSV vaccine.
Novo Nordisk beats profit estimates as sales of weight loss drug Wegovy more than double
Sales of popular weight loss drug Wegovy more than doubled to 9.38 billion kroner.